Tuncel M et al. |
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. |
2007 |
Cancer Biother. Radiopharm. |
pmid:17600477
|
Tuncel M et al. |
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. |
2007 |
Cancer Biother. Radiopharm. |
pmid:17679169
|
Cao QF et al. |
TRPM2 mediates histone deacetylase inhibition-induced apoptosis in bladder cancer cells. |
2015 |
Cancer Biother. Radiopharm. |
pmid:25760728
|
Yamashita K et al. |
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. |
2002 |
Cancer Cell |
pmid:12498717
|
Gius D et al. |
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. |
2004 |
Cancer Cell |
pmid:15488759
|
Maecker HL et al. |
Epigenetic changes in tumor Fas levels determine immune escape and response to therapy. |
2002 |
Cancer Cell |
pmid:12204534
|
Jiang X et al. |
DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. |
2008 |
Cancer Cell |
pmid:18538736
|
Brugarolas JB et al. |
TSC2 regulates VEGF through mTOR-dependent and -independent pathways. |
2003 |
Cancer Cell |
pmid:12957289
|
Yoshida M et al. |
Histone deacetylase as a new target for cancer chemotherapy. |
2001 |
Cancer Chemother. Pharmacol. |
pmid:11587361
|
Bovenzi V and Momparler RL |
Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. |
2001 |
Cancer Chemother. Pharmacol. |
pmid:11488527
|
Whang YM et al. |
Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells. |
2005 |
Cancer Chemother. Pharmacol. |
pmid:15959780
|
Kang J et al. |
Synergistic killing of human leukemia cells by antioxidants and trichostatin A. |
2004 |
Cancer Chemother. Pharmacol. |
pmid:15248029
|
Fandy TE and Srivastava RK |
Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins. |
2006 |
Cancer Chemother. Pharmacol. |
pmid:16435155
|
Wunder T et al. |
Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. |
2013 |
Cancer Gene Ther. |
pmid:23196273
|
El-Zawahry A et al. |
In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL. |
2006 |
Cancer Gene Ther. |
pmid:16167063
|
Katsura T et al. |
The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells. |
2009 |
Cancer Gene Ther. |
pmid:18949013
|
Zhou X et al. |
The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. |
2007 |
Cancer Genet. Cytogenet. |
pmid:17693185
|
Mazzio EA and Soliman KFA |
Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A. |
|
Cancer Genomics Proteomics |
pmid:30194076
|
Mazzio EA and Soliman KF |
HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells. |
2017 |
Cancer Genomics Proteomics |
pmid:28031235
|
Shin S et al. |
Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes. |
|
Cancer Genomics Proteomics |
pmid:28871002
|
Khan AN et al. |
An epigenetically altered tumor cell vaccine. |
2004 |
Cancer Immunol. Immunother. |
pmid:14997346
|
Khan AN et al. |
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells. |
2008 |
Cancer Immunol. Immunother. |
pmid:18046553
|
Tiper IV and Webb TJ |
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma. |
2016 |
Cancer Immunol. Immunother. |
pmid:27614429
|
Neumann F et al. |
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors. |
2013 |
Cancer Immunol. Immunother. |
pmid:23619976
|
Meng CF et al. |
Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. |
2010 |
Cancer Invest. |
pmid:19857042
|
Fang Y et al. |
Synergistic efficacy in human ovarian cancer cells by histone deacetylase inhibitor TSA and proteasome inhibitor PS-341. |
2011 |
Cancer Invest. |
pmid:21345073
|
Liu Y et al. |
Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. |
2008 |
Cancer Invest. |
pmid:18584348
|
Mousa SA et al. |
Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers. |
2010 |
Cancer Lett. |
pmid:19733430
|
Sugimoto S et al. |
Expression and regulation of tumor suppressor gene maspin in human bladder cancer. |
2004 |
Cancer Lett. |
pmid:14732229
|
Li Y et al. |
Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors. |
2012 |
Cancer Lett. |
pmid:22266186
|
Jung EJ et al. |
Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. |
2007 |
Cancer Lett. |
pmid:16647201
|
Davies GF et al. |
Troglitazone inhibits histone deacetylase activity in breast cancer cells. |
2010 |
Cancer Lett. |
pmid:19699029
|
Hostetter CL et al. |
Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity. |
2009 |
Cancer Lett. |
pmid:19013015
|
Francisco R et al. |
Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. |
2012 |
Cancer Lett. |
pmid:22186300
|
Pitta CA et al. |
Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance. |
2013 |
Cancer Lett. |
pmid:23752064
|
Nair AR et al. |
Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA. |
2001 |
Cancer Lett. |
pmid:11295287
|
Zhang Q et al. |
Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis. |
2014 |
Cancer Lett. |
pmid:25109451
|
Liu RF et al. |
Down-regulation of miR-517a and miR-517c promotes proliferation of hepatocellular carcinoma cells via targeting Pyk2. |
2013 |
Cancer Lett. |
pmid:23142219
|
Chen H et al. |
LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. |
2012 |
Cancer Lett. |
pmid:22743615
|
Januchowski R et al. |
Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells. |
2007 |
Cancer Lett. |
pmid:16624484
|
Koh E et al. |
Trichostatin A and 5-aza-2'-deoxycytidine switch S1P from an inhibitor to a stimulator of motility through epigenetic regulation of S1P receptors. |
2007 |
Cancer Lett. |
pmid:17189669
|
Bharadwaj S and Prasad GL |
Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. |
2002 |
Cancer Lett. |
pmid:12065096
|
Bazhin AV et al. |
Expression of GAGE family proteins in malignant melanoma. |
2007 |
Cancer Lett. |
pmid:17194529
|
Al-Rayyan N et al. |
5-Aza-2-deoxycytidine and trichostatin A increase COUP-TFII expression in antiestrogen-resistant breast cancer cell lines. |
2014 |
Cancer Lett. |
pmid:24513177
|
Chen Z et al. |
Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells. |
2002 |
Cancer Lett. |
pmid:12406558
|
Gálfi P et al. |
Apoptosis sensitivity is not correlated with sensitivity to proliferation inhibition by the histone deacetylase inhibitors butyrate and TSA. |
2002 |
Cancer Lett. |
pmid:12406559
|
Ryu JK et al. |
SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines. |
2006 |
Cancer Lett. |
pmid:16009488
|
Jung JW et al. |
Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by H2O2- and 12-O-tetradecanoylphorbol-13-acetate in rat liver epithelial cells. |
2006 |
Cancer Lett. |
pmid:16337085
|
Ohike N et al. |
Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. |
2003 |
Cancer Lett. |
pmid:12969792
|
Hoebeeck J et al. |
Aberrant methylation of candidate tumor suppressor genes in neuroblastoma. |
2009 |
Cancer Lett. |
pmid:18819746
|